Arbutus Biopharma Corp

ABUSNASDAQ · USD
4.02USD0.00 (-1.23%)
735

Arbutus Biopharma Corp (ABUS) Option Chain

Read more

Tracking the ABUS option chain helps you see every strike and expiry on Arbutus Biopharma Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABUS options activity at a glance. Use our scanner to monitor the ABUS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABUS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ABUS options are being actively traded, and where they are not.

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destabilize HBV RNA, which leads in the reduction of HBsAg and other viral proteins; AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune response; and small molecule antiviral medicines to treat coronaviruses, including COVID-19.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
42.59410-0.241.020.101.453.00-25.37—2.350.002.350057.41
52.71000.480.52—1.003.50-12.94—1.650.001.650047.29
61.373100.530.02—0.554.00-0.50—0.750.000.750238.63
68.57100.400.00—0.404.50+11.940.204.900.482.070031.43
74.4773500.100.00—0.105.00+24.380.702.800.980.7702525.53

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank83.33% High
  • Market cap (M$)616
  • 52 weeks high-26.24%
  • 52 weeks low14.86%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$5.50
    36.82% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-10
  • P/E3.59
  • Future P/E—
  • EPS (ttm)1.12
  • EPS growth next 5 years—

As of Nov 20, 2026